NEPHROGEN Trademark

Trademark Overview

On Wednesday, October 21, 2015, a trademark application was filed for NEPHROGEN with the United States Patent and Trademark Office. The USPTO has given the NEPHROGEN trademark a serial number of 86794404. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, September 8, 2023. This trademark is owned by Nephrogen, Inc.. The NEPHROGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of therapeutics, medical devices, pharmaceuticals, and lab equipment for the treatment of kidney disease, cancer, diabetes, and heart disease in patients; Development of new technology for others in the field of therapeutics for the treatment of kidney disease, cancer, diabetes, and heart disease in patients
nephrogen

General Information

Serial Number86794404
Word MarkNEPHROGEN
Filing DateWednesday, October 21, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, September 8, 2023
Registration Number5261761
Registration DateTuesday, August 8, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2016

Trademark Statements

Goods and ServicesDevelopment of new technology for others in the field of therapeutics, medical devices, pharmaceuticals, and lab equipment for the treatment of kidney disease, cancer, diabetes, and heart disease in patients; Development of new technology for others in the field of therapeutics for the treatment of kidney disease, cancer, diabetes, and heart disease in patients

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2016
Primary Code042
First Use Anywhere DateMonday, August 24, 2015
First Use In Commerce DateMonday, August 24, 2015

Trademark Owner History

Party NameNephrogen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10027
Party NameNephrogen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02420
Party NameNephrogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02420

Trademark Events

Event DateEvent Description
Friday, September 8, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 8, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, September 8, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 9, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, August 8, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 27, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 27, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 8, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 4, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 3, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 30, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, June 5, 2017USE AMENDMENT FILED
Friday, June 30, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 5, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, December 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 7, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 23, 2016ASSIGNED TO LIE
Tuesday, August 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 16, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 16, 2016NON-FINAL ACTION E-MAILED
Tuesday, February 16, 2016NON-FINAL ACTION WRITTEN
Thursday, February 11, 2016ASSIGNED TO EXAMINER
Monday, October 26, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 24, 2015NEW APPLICATION ENTERED

Related Keywords

nephrogen disease development diabetes kidney heart treatment patients technology others field